Comparative Study of Diallyl-Disulphide and Dipropyl-Disulphide in Experimental Atherosclerosis
Keywords:
diallyl disulphide, dipropyl disulphide, atherosclerosis, lipid profile, acrolein
Abstract
Diallyl disulphide, the principle organosulphur compound of garlic oil, is known to possess many clinical beneficial effects, but its overuse or abuse has been reported to cause certain harmful side effects due to its possible metabolite acrolein. It was thought that the disulphide nature of diallyl disulphide is responsible for its hypolipidemic effect and the unsaturation may be for its toxic effects. Recently few synthetic disulphides are successfully employed in experimentally induced hyperlipidemia. The present study was under taken to compare the hypolipidemic as well as toxic effects of saturated disulphide, Dipropyl disulphide with Diallyl disulphide. The atherogenic diet fed male albino rats were given orally 100mg/kg body weight of disulphide (DADS or DPDS) for 60 days, later the rats were sacrificed and the plasma lipid profile, glycoproteins, calcium and transaminases were estimated. The aortic homogenates were employed for the estimation of thiobarbituric acid reactive substances and total sulphhydryl group. The results indicate a significant hypolipidemic effect with dipropyl disulphide with a comparative lower toxic side effect. It is concluded that DPDS is much safer and equally good hypolipidemic agent in experimentally induced hyperlipidemia in albino rats.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2013-01-15
Issue
Section
License
Copyright (c) 2013 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.